Wanda Moebius has been named VP of policy communications of AdvaMed (Washington). Moebius most recently served as senior director of communications at the Pharmaceutical Research and Manufacturers of America.
Jacob Victor, PhD, has been named executive director of product development, clinical diagnostics, of Alteon (Montvale, New Jersey). Most recently, Victor directed the development, manufacture and successful FDA-clearance for eight leading-edge HLA, DNA and antibody typing diagnostic kits for the company. Alteon makes products to treat and prevent cardiovascular disease and to treat nephropathy in people with diabetes.
W. Eugene Sanders Jr, MD, was named VP of medical affairs and chief medical officer of InnerPulse (Research Triangle Park, North Carolina), effective in September. Sanders currently is director, clinical cardiac electrophysiology and pacing; associate director, cardiovascular diagnostic and interventional laboratories; and, associate professor of medicine and pathology, division of cardiology at the University of North Carolina Hospitals. InnerPulse is a private company specializing in technology used to treat abnormal heart rhythms.
Len Farris has been named VP of marketing for OmniSonics Medical Technologies (Wilmington, Massachusetts). Farris most recently worked at Boston Scientific as global director of marketing. OmniSonics is focused on developing products to treat vascular occlusive disease.
Mary Ellen Harrison has been named VP of business development for Sensei (Boca Raton, Florida). Previously she was executive VP of global strategy and business development for a joint venture company funded by Oracle and Alcate. Sensei develops web-based solutions for diabetes, hypertension, smoking, cardiovascular risk, stress and asthma.
VNUS Medical Technologies (VNUS; San Jose, California) reported the resignation of Charlene Friedman, VP of general counsel and corporate secretary, effective July 20. VNUS makes products for the minimally invasive treatment of venous reflux disease.
WomenHeart: the National Coalition for Women with Heart Disease (Washington) named Lisa Tate its new CEO. WomenHeart said that Tate brings more than two decades of experience in health advocacy. WomenHeart bills itself as the only national advocacy organization focused on the healthcare of women with heart disease.